Diagnostics

With COVID revenue fading, QuidelOrtho will use a key conference to prove its diversified diagnostics model can deliver on growth, margins, and cash flow.

A new, affordable sonography degree in Southwest Kansas aims to fill critical healthcare jobs and keep local talent at home through a unique partnership.

A groundbreaking, NIH-funded trial will use advanced PET imaging to test new Alzheimer's drugs, with XingImaging managing the critical visual data.

Flatiron Health launches a first-of-its-kind AI platform, merging data from 400,000 patients to revolutionize prostate cancer research and treatment.

With a new veteran chairman and validated at-home testing, Fellow Health is poised to disrupt the male fertility market. Here's what the move means.

Photocure reports robust Q4 earnings and a strong 2026 forecast, while pivoting to an AI-driven future for bladder cancer diagnostics and global expansion.

A groundbreaking collaboration is turning discarded biopsy material into a powerful tool for AI-driven cancer diagnostics, promising a new era of proactive care.

With over 2 million visitors at Expo 2025, Thailand showcased breakthrough medical tech. But can it translate this success into a global healthcare powerhouse?

As dental practices face critical labor shortages, a new wave of AI-powered platforms like Jobley aims to revolutionize hiring. But is it the cure?

Pioneering surgeon Dr. Gopal H. Badlani receives a top honor for his decades of work building sustainable urological care in underserved nations.

A new study shows an AI-powered device can identify infants at high risk for atopic dermatitis at birth, paving the way for proactive, preventative care.

Copan's PhenoMATRIX® gains FDA 510(k) clearance, unleashing AI to speed up bacterial analysis and reshape the future of clinical diagnostics in America.

Integrity College of Health's maximum six-year reaccreditation offers a key validation for parent company Legacy Education amid a shifting regulatory climate.

A major update to the Kosmos platform brings cart-grade OB/GYN and vascular tools to a portable device, reshaping diagnostics from the ER to rural clinics.

In a landmark $9.9 billion all-cash deal, Danaher will acquire Masimo, aiming to dominate the patient monitoring market from hospital to home.

Annexon Biosciences spotlights its novel C1q inhibitor, Vonaprument, aiming to be the first therapy to preserve vision in geographic atrophy patients.

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

Israeli tech firm Nanox will debut its low-cost Nanox.ARC imaging system in Europe, pairing it with AI that spots chronic disease in routine scans.

Fresh off its IPO, Lumexa Imaging's leadership heads to key conferences. Here’s what’s at stake as they pitch their growth strategy to investors.

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.